Comments on: Neoadjuvant Nivolumab Plus Relatlimab Appears Safe and Effective in NSCLC https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/neoadjuvant-nivolumab-relatlimab-nsclc-safe-effective/ Thu, 04 Jan 2024 20:12:07 +0000 hourly 1 https://wordpress.org/?v=6.4.3